Loading insider details...
Beta
Latest Form 4 (Oct 2, 2026): Exercise/Conversion of 9,229 PTGX shares, $359.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Protagonist Therapeutics, Inc (PTGX) | Exercise/Conversion | 9,229 | $359.7K |
| Apr 21, 2026 | Protagonist Therapeutics, Inc (PTGX) | Sale | 1,750 | $184.6K |
| Mar 27, 2026 | Protagonist Therapeutics, Inc (PTGX) | Exercise/Conversion | 19,500 | $374.2K |
| Jan 28, 2026 | Protagonist Therapeutics, Inc (PTGX) | Exercise/Conversion | 16,000 | $307.0K |
| Jan 21, 2026 | Protagonist Therapeutics, Inc (PTGX) | Sale | 8,588 | $708.3K |
| Jan 7, 2026 | Protagonist Therapeutics, Inc (PTGX) | Grant/Award | 25,600 | n/a |
| Apr 23, 2025 | Protagonist Therapeutics, Inc (PTGX) | Sale | 1,756 | $80.8K |
| Mar 14, 2025 | Protagonist Therapeutics, Inc (PTGX) | Exercise/Conversion | 15,203 | $185.0K |
| Jan 17, 2025 | Protagonist Therapeutics, Inc (PTGX) | Sale | 1,317 | n/a |
| Jan 6, 2025 | Protagonist Therapeutics, Inc (PTGX) | Grant/Award | 31,779 | n/a |